Published in Biochem J on October 15, 1993
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A (1999) 3.85
Mint3/X11gamma is an ADP-ribosylation factor-dependent adaptor that regulates the traffic of the Alzheimer's Precursor protein from the trans-Golgi network. Mol Biol Cell (2007) 1.09
Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol (1995) 1.07
Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells. Exp Brain Res (2011) 1.03
Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Am J Pathol (1995) 0.97
The Amyloid Precursor Protein is rapidly transported from the Golgi apparatus to the lysosome and where it is processed into beta-amyloid. Mol Brain (2014) 0.85
Structural aspects and physiological consequences of APP/APLP trans-dimerization. Exp Brain Res (2011) 0.84
cDNA isolation of Alzheimer's amyloid precursor protein from cholinergic nerve terminals of the electric organ of the electric ray. Biochem J (1998) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem (1981) 26.33
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (1987) 17.08
Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J Cell Biol (1982) 14.41
The trans Golgi network: sorting at the exit site of the Golgi complex. Science (1986) 10.08
NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J Biol Chem (1990) 5.91
Externally disposed plasma membrane proteins. I. Enzymatic iodination of mouse L cells. J Cell Biol (1975) 5.82
Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell (1983) 5.71
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11
Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J Cell Biol (1982) 5.11
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell (1989) 4.99
Exit of newly synthesized membrane proteins from the trans cisterna of the Golgi complex to the plasma membrane. J Cell Biol (1985) 4.93
Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science (1990) 4.91
Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature (1988) 4.83
A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn (1981) 4.73
A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell (1992) 4.39
Protein degradation in the endoplasmic reticulum. Cell (1990) 4.04
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature (1988) 3.99
Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature (1992) 3.22
Polarized apical distribution of glycosyl-phosphatidylinositol-anchored proteins in a renal epithelial cell line. Proc Natl Acad Sci U S A (1988) 3.19
Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science (1990) 3.10
Phorbol esters and horseradish peroxidase stimulate pinocytosis and redirect the flow of pinocytosed fluid in macrophages. J Cell Biol (1985) 3.02
Kinetics of intracellular transport and sorting of lysosomal membrane and plasma membrane proteins. J Cell Biol (1987) 3.02
Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A (1988) 2.95
Transport of the lysosomal membrane glycoprotein lgp120 (lgp-A) to lysosomes does not require appearance on the plasma membrane. J Cell Biol (1992) 2.86
Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science (1992) 2.82
An enzymatic assay reveals that proteins destined for the apical or basolateral domains of an epithelial cell line share the same late Golgi compartments. EMBO J (1985) 2.78
Isolation of rat liver plasma membrane fragments in isotonic sucrose. Methods Enzymol (1974) 2.62
Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci U S A (1992) 2.55
Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci U S A (1990) 2.41
A His-Leu-Leu sequence near the carboxyl terminus of the cytoplasmic domain of the cation-dependent mannose 6-phosphate receptor is necessary for the lysosomal enzyme sorting function. J Biol Chem (1992) 2.39
Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J (1988) 2.26
The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disord (1992) 2.24
Endocytosis and signals for internalization. Curr Opin Cell Biol (1991) 2.22
Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science (1992) 2.12
Tyrosine sulfation is a trans-Golgi-specific protein modification. J Cell Biol (1987) 2.10
The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature (1989) 1.94
Enzymic diagnosis of the genetic mucopolysaccharide storage disorders. Methods Enzymol (1978) 1.89
The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J Biol Chem (1990) 1.83
Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem (1993) 1.81
Lectin-binding sites as markers of Golgi subcompartments: proximal-to-distal maturation of oligosaccharides. J Cell Biol (1983) 1.74
The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci U S A (1989) 1.73
Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci (1991) 1.70
Low temperature-induced transport blocks as tools to manipulate membrane traffic. Methods Cell Biol (1989) 1.46
The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp Neurol (1989) 1.45
Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci U S A (1992) 1.40
Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor. J Neurosci (1990) 1.38
Amyloid beta protein precursor and the pathogenesis of Alzheimer's disease. Cell (1989) 1.31
Monensin and brefeldin A differentially affect the phosphorylation and sulfation of secretory proteins. J Biol Chem (1992) 1.27
Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci Lett (1991) 1.26
Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science (1990) 1.26
The lysosomal membrane glycoprotein lamp-1 is transported to lysosomes by two alternative pathways. Arch Biochem Biophys (1992) 1.17
Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels. Proc Natl Acad Sci U S A (1992) 1.12
Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J Neurosci Res (1992) 1.11
Phase separation of the receptor for immunoglobulin E and its subunits in Triton X-114. J Biol Chem (1984) 1.07
Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci U S A (1991) 0.99
Isolation of a fraction enriched in the trans-Golgi network from baby hamster kidney cells. Exp Cell Res (1988) 0.92
Alzheimer's amyloid precursor protein produced by recombinant baculovirus expression. Proteolytic processing and protease inhibitory properties. J Biol Chem (1991) 0.92
Alzheimer beta/A4-amyloid precursor protein: evidence for putative amyloidogenic fragment. J Neurochem (1992) 0.91
Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity. Biochem Biophys Res Commun (1992) 0.91
The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton. J Neurosci (1991) 0.89
The Alzheimer's amyloid precursor protein is produced by type I astrocytes in primary cultures of rat neuroglia. J Neurosci Res (1990) 0.89
Release of amino-terminal fragments from amyloid precursor protein reporter and mutated derivatives in cultured cells. J Biol Chem (1992) 0.88
Evidence for a nonsecretory, acidic degradation pathway for amyloid precursor protein in 293 cells. Identification of a novel, 22-kDa, beta-peptide-containing intermediate. J Biol Chem (1992) 0.87
Ultrastructural localization of the putative precursors of the A4 amyloid protein associated with Alzheimer's disease. Am J Pathol (1990) 0.85
Characterization of beta-amyloid precursor proteins with or without the protease-inhibitor domain using anti-peptide antibodies. J Neurochem (1990) 0.83
Beta-amyloid precursor protein localization in the Golgi apparatus in neurons and oligodendrocytes. An immunocytochemical structural and ultrastructural study in normal and axotomized neurons. Brain Res Mol Brain Res (1992) 0.83
The beta-amyloid precursor protein is not processed by the regulated secretory pathway. Biochem Biophys Res Commun (1991) 0.83
Alpha 2-macroglobulin and other proteinase inhibitors do not interfere with the secretion of amyloid precursor protein in mouse neuroblastoma cells. FEBS Lett (1992) 0.78
Protease inhibitors generate cytotoxic fragments from Alzheimer amyloid protein precursor in cDNA-transfected glioma cells. Biochem Biophys Res Commun (1992) 0.78
Differential expression of carboxyl terminal derivatives of amyloid precursor protein among cell lines. J Neurosci Res (1992) 0.77
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Human mitochondrial DNA variation and evolution: analysis of nucleotide sequences from seven individuals. Genetics (1983) 9.22
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology (1989) 5.24
Intraspecific nucleotide sequence variability surrounding the origin of replication in human mitochondrial DNA. Gene (1983) 4.47
Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging (1996) 3.38
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02
Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. Cell (1995) 2.89
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. J Clin Oncol (2002) 2.70
Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet (1987) 2.42
Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet (1996) 2.18
Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science (1992) 2.12
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry (2003) 2.12
Prevalence and causes of blindness and visual impairment in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh. Br J Ophthalmol (2003) 2.09
Determinants of mortality among children in the urban slums of Dhaka city, Bangladesh. Trop Med Int Health (1999) 1.74
Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen. J Clin Oncol (2003) 1.72
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
Ethical dilemma: discontinuation of ventilation after brain stem death. BMJ (1999) 1.63
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J Neurochem (1993) 1.52
Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J Neurosci (1998) 1.50
Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health (1999) 1.50
A comparative clinical trial of artemether and quinine in children with severe malaria. Indian Pediatr (2003) 1.49
Universal scaling laws of diffusion in a binary fluid mixture. Phys Rev Lett (2001) 1.41
In vitro models for the blood-brain barrier. Toxicol In Vitro (2005) 1.41
Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem (1998) 1.36
Yeast 2-micrometer plasmid DNA replication in vitro: origin and direction. Proc Natl Acad Sci U S A (1981) 1.36
Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry (1999) 1.33
Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci U S A (1990) 1.31
Obturator hernia: the Mayo Clinic experience. Hernia (2011) 1.30
Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Abeta sequence. J Biol Chem (1996) 1.30
Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry (2000) 1.29
Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J Neurosci (1991) 1.27
Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med (2011) 1.25
Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry (2006) 1.24
The incidentally discovered asymptomatic adrenal tuberculous mass mimicking malignancy. Bangladesh Med Res Counc Bull (1999) 1.23
Nucleotide sequence of the gene encoding human atrial natriuretic factor precursor. Nature (1985) 1.23
Are pencil point needles safe for subarachnoid block? Anaesthesia (1998) 1.21
Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet (2009) 1.21
Outcomes of cataract surgery in Bangladesh: results from a population based nationwide survey. Br J Ophthalmol (2003) 1.18
Menstrual cycle effects on cortical excitability. Neurology (1999) 1.17
A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport (1997) 1.15
Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry (2006) 1.13
Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res (1993) 1.13
Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res (1999) 1.13
Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neurol (1991) 1.12
Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer. J Clin Pathol (2014) 1.12
Molecular characterization of high-level-cholera-toxin-producing El Tor variant Vibrio cholerae strains in the Zanzibar Archipelago of Tanzania. J Clin Microbiol (2013) 1.08
Novel beta-secretase cleavage of beta-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells. J Cell Biol (1997) 1.07
Assignment of a polymorphic polypeptide to the human mitochondrial DNA unidentified reading frame 3 gene by a new peptide mapping strategy. J Biol Chem (1983) 1.06
Treatment of depression by obstetrician-gynecologists: a survey study. Obstet Gynecol (1997) 1.06
Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J Pharm Sci (1994) 1.05
Motor cortex excitability correlates with an anxiety-related personality trait. Biol Psychiatry (2001) 1.05
Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies. Gynecol Oncol (2013) 1.04
Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J Pharm Sci (1995) 1.03
A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet B Neuropsychiatr Genet (2009) 1.03
Trends in emergent inguinal hernia surgery in Olmsted County, MN: a population-based study. Hernia (2012) 1.02
Primaquine blocks transport by inhibiting the formation of functional transport vesicles. Studies in a cell-free assay of protein transport through the Golgi apparatus. J Biol Chem (1991) 1.02
Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Trop Pediatr (2009) 1.00
Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry (1999) 1.00
Molecular features of hypothalamic plaques in Alzheimer's disease. Am J Pathol (1991) 1.00
Hydatidosis: experience with hepatic and pulmonary hydatid disease. J Pak Med Assoc (1998) 0.98
beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. Neuropathol Appl Neurobiol (2000) 0.98
The activity of Golgi transport vesicles depends on the presence of the N-ethylmaleimide-sensitive factor (NSF) and a soluble NSF attachment protein (alpha SNAP) during vesicle formation. J Cell Biol (1992) 0.98
Bone markers in the management of metastatic bone disease. Cancer Treat Rev (2001) 0.98
Obsessive-compulsive disorder: subclassification based on co-morbidity. Psychol Med (2008) 0.97
Epidemiological study of endemic cretinism in a hyperendemic area. Bangladesh Med Res Counc Bull (1997) 0.97
Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am J Pathol (1993) 0.97
Hexose uptake in primary cultures of bovine brain microvessel endothelial cells. I. Basic characteristics and effects of D-glucose and insulin. Biochim Biophys Acta (1991) 0.96
Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs. Neurobiol Aging (1996) 0.95
Comparison of the Kato-Katz method and ether-concentration technique for the diagnosis of soil-transmitted helminth infections in the framework of a randomised controlled trial. Eur J Clin Microbiol Infect Dis (2013) 0.95
Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein. J Pharm Pharmacol (1999) 0.94
Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis (2012) 0.94
Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet (2013) 0.93
5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet (1998) 0.93
Rank-order of potencies for inhibition of the secretion of abeta40 and abeta42 suggests that both are generated by a single gamma-secretase. J Biol Chem (1999) 0.93
Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis (2013) 0.93
Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects. Am J Psychiatry (1998) 0.93
Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro. Eur J Biochem (1994) 0.92
Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study. Mol Psychiatry (2009) 0.92
Spontaneous choledochoduodenal fistula with tuberculous duodenal ulceration. Ann R Coll Surg Engl (2014) 0.92
Alzheimer's amyloid precursor protein produced by recombinant baculovirus expression. Proteolytic processing and protease inhibitory properties. J Biol Chem (1991) 0.92
Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia (1994) 0.92
Total synthesis of cryptophycin-24 (Arenastatin A) amenable to structural modifications in the C16 side chain. J Org Chem (2000) 0.91
Consanguineous marriages in Pakistan. Pak Dev Rev (1994) 0.91
Structure-activity studies of antitumor taxanes: synthesis of novel C-13 side chain homologated taxol and taxotere analogs. J Med Chem (1994) 0.91
Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab. Ann Oncol (2011) 0.90
Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. J Med Chem (1999) 0.90
Role of the serotonin transporter gene in temperament and character. J Pers Disord (1999) 0.90
Rapid diagnosis of Helicobacter pylori infection in dyspeptic patients using salivary secretion: a non-invasive approach. Singapore Med J (2005) 0.89
Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab Invest (1992) 0.89
Enhancement of CO2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline. Am J Psychiatry (1999) 0.89
New nonsurgical technique for multiple pericardial biopsies. Cathet Cardiovasc Diagn (1988) 0.88
Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease. Am J Pathol (1992) 0.88
Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol Psychiatry (2001) 0.86
Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approach. J Abnorm Psychol (2000) 0.86
Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Res (2001) 0.86
Serotonin transporter candidate gene studies in affective disorders and personality: promises and potential pitfalls. Mol Psychiatry (1998) 0.86
Alzheimer's disease: beta-amyloid precursor protein expression in plaques varies among cytoarchitectonic areas of the medial temporal lobe. Neurosci Lett (1991) 0.86